CpG-oligonucleotides in vaccination: signaling and mechanisms of action.
Dalpke
A
A
Institute of Medical Microbiology and Hygiene, Philipps-University Marburg, Germany.
Zimmermann
S
S
Heeg
K
K
D000276:Adjuvants, Immunologic; D000818:Animals; D018899:CpG Islands / Q000276:immunology*; D029721:Drosophila Proteins; D025461:Feedback, Physiological / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology; D008562:Membrane Glycoproteins / Q000276:immunology; D009838:Oligodeoxyribonucleotides / Q000276:immunology*; D011956:Receptors, Cell Surface / Q000276:immunology; D015398:Signal Transduction / Q000276:immunology*; D051193:Toll-Like Receptors; D014611:Vaccination / Q000379:methods
D000276:Adjuvants, Immunologic; C408982:CPG-oligonucleotide; D029721:Drosophila Proteins; D008562:Membrane Glycoproteins; D009838:Oligodeoxyribonucleotides; D011956:Receptors, Cell Surface; D051193:Toll-Like Receptors